title: Are there differences in type, dosage, and method of administration for the systemic steroids in IBD treatment?
authors.affiliation: Center of Excellence for Gastrointestinal Inflammation and Immunity Research (CEGIIR), Division of Gastroenterology, University of Alberta, Alberta, Canada.
authors.forename: Christopher
authors.initials: C
authors.lastname: Teshima
authors.forename: Richard N
authors.initials: RN
authors.lastname: Fedorak
mesh_terms: D003093:Colitis, Ulcerative / Q000188:drug therapy* / Q000473:pathology; D003424:Crohn Disease / Q000188:drug therapy* / Q000473:pathology; D004305:Dose-Response Relationship, Drug; D004333:Drug Administration Routes; D004334:Drug Administration Schedule; D005938:Glucocorticoids / Q000008:administration & dosage* / Q000009:adverse effects*; D006801:Humans; D008775:Methylprednisolone / Q000008:administration & dosage / Q000009:adverse effects; D011239:Prednisolone / Q000008:administration & dosage / Q000009:adverse effects; D011241:Prednisone / Q000008:administration & dosage / Q000009:adverse effects; D012074:Remission Induction / Q000379:methods; D055502:Secondary Prevention; D012720:Severity of Illness Index
chemical_list: D005938:Glucocorticoids; D011239:Prednisolone; D011241:Prednisone; D008775:Methylprednisolone